Harbour Investments Inc. trimmed its position in shares of Healthpeak Properties, Inc. (NYSE:DOC – Free Report) by 6.5% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 47,236 shares of the real estate investment trust’s stock after selling 3,302 shares during the period. Harbour Investments Inc.’s holdings in Healthpeak Properties were worth $957,000 as of its most recent SEC filing.
Other hedge funds also recently bought and sold shares of the company. JPMorgan Chase & Co. boosted its holdings in Healthpeak Properties by 23.2% during the third quarter. JPMorgan Chase & Co. now owns 21,561,640 shares of the real estate investment trust’s stock valued at $493,115,000 after acquiring an additional 4,056,931 shares during the period. Thrivent Financial for Lutherans bought a new stake in Healthpeak Properties during the third quarter valued at about $1,880,000. Pathstone Holdings LLC bought a new stake in shares of Healthpeak Properties in the third quarter valued at about $1,968,000. Swedbank AB bought a new stake in shares of Healthpeak Properties in the third quarter valued at about $1,832,000. Finally, Associated Banc Corp bought a new stake in shares of Healthpeak Properties in the third quarter valued at about $10,559,000. 93.57% of the stock is currently owned by institutional investors.
Healthpeak Properties Stock Performance
NYSE:DOC opened at $20.46 on Wednesday. The company has a current ratio of 1.35, a quick ratio of 1.35 and a debt-to-equity ratio of 0.96. The firm has a 50 day moving average of $20.23 and a 200-day moving average of $21.20. Healthpeak Properties, Inc. has a 1 year low of $17.21 and a 1 year high of $23.26. The stock has a market capitalization of $14.32 billion, a P/E ratio of 58.47, a price-to-earnings-growth ratio of 2.17 and a beta of 1.14.
Healthpeak Properties Increases Dividend
Analyst Upgrades and Downgrades
DOC has been the subject of several research reports. Morgan Stanley upgraded shares of Healthpeak Properties from an “equal weight” rating to an “overweight” rating and set a $25.00 target price for the company in a research note on Wednesday, January 15th. Mizuho reduced their target price on shares of Healthpeak Properties from $25.00 to $24.00 and set an “outperform” rating for the company in a research note on Thursday, December 5th. Scotiabank reduced their target price on shares of Healthpeak Properties from $24.00 to $23.00 and set a “sector outperform” rating for the company in a research note on Friday, February 28th. Wells Fargo & Company dropped their price target on shares of Healthpeak Properties from $23.00 to $22.00 and set an “equal weight” rating for the company in a research report on Tuesday, December 10th. Finally, Robert W. Baird dropped their price target on shares of Healthpeak Properties from $25.00 to $24.00 and set an “outperform” rating for the company in a research report on Tuesday, February 11th. Four investment analysts have rated the stock with a hold rating, ten have issued a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat.com, Healthpeak Properties currently has a consensus rating of “Moderate Buy” and a consensus target price of $23.92.
Get Our Latest Stock Report on DOC
About Healthpeak Properties
Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.
Read More
- Five stocks we like better than Healthpeak Properties
- Unveiling The Power Of VWAP: A Key Indicator For Traders
- Arqit Stock Soars as NVIDIA’s GTC Fuels Quantum Excitement
- Stock Trading Terms – Stock Terms Every Investor Needs to Know
- 3 Must-Own Stocks to Build Wealth This Decade
- What is the Hang Seng index?
- Advanced Micro Devices Eyes AI Market Growth—Is AMD a Buy?
Receive News & Ratings for Healthpeak Properties Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthpeak Properties and related companies with MarketBeat.com's FREE daily email newsletter.